Acurx Pharmaceuticals (ACXP) Net Equity Issued and Repurchased (2022 - 2026)
Acurx Pharmaceuticals' (ACXP) quarterly Net Equity Issued and Repurchased came in at $3.1 million in Q1 2026, up 11.96% on a QoQ basis from $2.8 million in Q4 2024.
Acurx Pharmaceuticals (ACXP) Net Equity Issued and Repurchased (2022 - 2026) Analysis & Trends
Acurx Pharmaceuticals (ACXP) has 3 years of Net Equity Issued and Repurchased data on file, last reported at $3.1 million in Q1 2026.
- Quarterly Net Equity Issued and Repurchased changed N/A year-over-year to $3.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $7.5 million (changed N/A YoY) and the FY2025 annual result came in at $4.0 million, down 56.52% from the prior year.
- Net Equity Issued and Repurchased improved to $3.1 million in Q1 2026, from $2.8 million in the prior quarter.
- In the past five years, Net Equity Issued and Repurchased ranged from a high of $3.1 million in Q1 2026 to a low of -$1.0 in Q4 2022.
- A 3-year average of $1.9 million and a median of $2.2 million in 2024 frame the typical range for Net Equity Issued and Repurchased.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 49.20 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Acurx Pharmaceuticals | 6.38 Mn | 6.38 Mn | - | 854,954.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 854,954.00 |
| Jun 30, 2026 | 854,954.00 |
| Mar 31, 2026 | 3.13 Mn |
| Mar 31, 2026 | 3.13 Mn |
| Dec 31, 2024 | 2.80 Mn |
| Dec 31, 2024 | 2.80 Mn |
| Sep 30, 2024 | 1.60 Mn |
| Sep 30, 2024 | 1.60 Mn |
| Dec 31, 2022 | -1.00 |
| Dec 31, 2022 | -1.00 |